Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001288503 | SCV001475663 | likely benign | not provided | 2019-12-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001288503 | SCV001673272 | likely benign | not provided | 2022-08-24 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002327625 | SCV002601699 | benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs200351196 with MODY3. | |
Ambry Genetics | RCV002327625 | SCV002695179 | likely benign | Maturity onset diabetes mellitus in young | 2022-06-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |